Review: Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects

A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07

(2017) N. Wolmark et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08

(2017) N. Wolmark et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)

(2009) M. Ychou et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinical implications of microsatellite instability in sporadic colon cancers

(2009) Frank A Sinicrope et al.   CURRENT OPINION IN ONCOLOGY

5LBA First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study)

(2009) D. Haller et al.   EJC SUPPLEMENTS

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial

(2009) P. Hoff et al.   EJC SUPPLEMENTS

Gastrosplenic Fistula From Hodgkin's Lymphoma

(2009) Carolyn D. Seib et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

(2009) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803

(2009) Monica M. Bertagnolli et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Serum Carcinoembryonic Antigen Level as a Predictive Factor of Recurrence After Curative Resection of Colorectal Cancer

(2008) Ryo Takagawa et al.   ANNALS OF SURGICAL ONCOLOGY

Adjuvant therapy for colon cancer: Present and perspectives

(2008) S. De Dosso et al.   CANCER TREATMENT REVIEWS

Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant Therapy

(2008) Hak-Mien Quah et al.   DISEASES OF THE COLON & RECTUM